Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Yuki Shiko

Biographic Data

ID7959458
NAMEYuki Shiko
GIVEN NAMESYuki
FAMILY NAMEShiko
SIGNATURESHIKO Y
AFFILIATIONSChiba University Hospital
ORCID0000-0002-3959-9343
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2024
H-INDEX0
  • Association of SLC6A3 variants with treatment-resistant schizophrenia

    Open Access•Masanobu Kogure, Nobuhisa Kanahara et al.•ARTICLE•Frontiers in Psychiatry•2024

    The overall results suggest that ( i ) SLC6A3 could be involved in responsiveness to antipsychotic medication and ( ii ) genetic variants modulating brain DA levels may be related to the classification of TRS and non-TRS

  • Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder

    Open Access•George Imataka, Kunio Yui et al.•ARTICLE•Frontiers in Psychiatry•2021

    The balance between antioxidant capacity and oxidative stress-induced free radicals may be crucial in the pathophysiological development factor of autism spectrum disorder (ASD). We measured the following urinary and plasma biomarker levels of oxidative stress and antioxidants. As urinary biomarkers, (1) hexanoyl-lysine (HEL), which is a new biomarker of oxidative stress, (2) the total antioxidant capacity (TAC), and (3) 8-hydroxy-2'-deoxyguanosi…

No prominent works on this page.

  • Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder

    Open Access•George Imataka, Kunio Yui et al.•ARTICLE•Frontiers in Psychiatry•2021

    The balance between antioxidant capacity and oxidative stress-induced free radicals may be crucial in the pathophysiological development factor of autism spectrum disorder (ASD). We measured the following urinary and plasma biomarker levels of oxidative stress and antioxidants. As urinary biomarkers, (1) hexanoyl-lysine (HEL), which is a new biomarker of oxidative stress, (2) the total antioxidant capacity (TAC), and (3) 8-hydroxy-2'-deoxyguanosi…

  • Association of SLC6A3 variants with treatment-resistant schizophrenia

    Open Access•Masanobu Kogure, Nobuhisa Kanahara et al.•ARTICLE•Frontiers in Psychiatry•2024

    The overall results suggest that ( i ) SLC6A3 could be involved in responsiveness to antipsychotic medication and ( ii ) genetic variants modulating brain DA levels may be related to the classification of TRS and non-TRS

Internal Medicine (2 works) · Medicine (2 works) · Psychiatry (2 works) · Allele (1 work) · Antioxidant (1 work) · Antipsychotic (1 work) · Autism (1 work) · Autism spectrum disorder (1 work) · Biochemistry (1 work) · Biology (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae